dr. finn on tivantinib and regorafenib for the treatment of liver cancer
Published 10 years ago • 196 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
1:11
regorafenib vs sorafenib in the treatment of liver cancer
-
1:34
dr. finn on results of resource study in liver cancer
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
4:33
managing systemic treatment in liver cancer
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
2:09
dr. finn on finding a biomarker for patients with hcc
-
3:48
clinical experience with regorafenib in hcc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
2:43
initial therapy options for liver cancer
-
4:32
therapeutic approach for hcc progression
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
5:31
practical advice for using regorafenib
-
2:18
dr. finn on biomarkers of response in hcc
-
1:09
survival benefit confirmed in real-life analysis of second-line regorafenib in hcc